Taiho Oncology, Inc.
Heather Riley has a diverse work experience in the pharmaceutical industry. Heather most recently worked as an Oncology Account Manager at Taiho Oncology, Inc. starting in September 2022. Prior to that, they were employed by AstraZeneca from 2016 to 2022, where they held multiple roles including Renal Metabolic Sales Specialist and Diabetes Sales Specialist.
Before joining AstraZeneca, Heather worked at Publicis Touchpoint Solutions as a Pharmaceutical Sales Representative from 2014 to 2016. In this role, they promoted respiratory products to allergists, pulmonologists, and general practitioners. Heather achieved notable accomplishments such as being the District Champion for Field Email to Physicians and winning the 2015 National Accelerate the Growth award.
Heather also gained valuable experience at PDI, where they worked from 2003 to 2014. As a Pharmaceutical Sales representative, they promoted various pharmaceutical products to dermatologists, cardiologists, pediatricians, and urologists. Heather was recognized for their contributions and served on the Advisory Board in 2012. Heather also mentored new hires during their time at PDI.
Heather'scareer in the pharmaceutical industry began at Pharmacia, where they worked as a Specialty Pharmaceutical Representative from 2000 to 2003. During this time, they focused on promoting women's health products to OBGYNs and successfully launched two new products.
Overall, Heather Riley has over two decades of experience in pharmaceutical sales and account management, with a particular emphasis on oncology, renal metabolism, diabetes, respiratory, dermatology, cardiology, pediatrics, urology, and women's health specialties.
Heather Riley attended The Ohio State University from 1989 to 2004, where they earned a Bachelor's degree in Human Ecology.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com